Recombinant PKC alpha antibody (pThr638)
Quick Overview for Recombinant PKC alpha antibody (pThr638) (ABIN7609949)
Target
See all PKC alpha (PKCa) AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- pThr638
-
Expression System
- HEK-293F Cells
-
Purpose
- Phospho-Prkca (T638) Recombinant Antibody
-
Characteristics
- The Phospho-Prkca (T638) Recombinant Antibody (Species: Human) has been validated for the following applications: ELISA, WB, IF.
-
Purification
- Affinity-Chromatography
-
Immunogen
- A Synthesized Peptide Derived From Human Phospho-Prkca (T638)
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Rabbit IgG in Phosphate Buffered Saline, pH 7.4, 150 mM NaCl, 0.02 % Sodium Azide and 50 % Glycerol
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- 2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
-
Expiry Date
- 12 months
-
-
- PKC alpha (PKCa) (Protein Kinase C, alpha (PKCa))
-
Alternative Name
- PRKCA
-
UniProt
- P17252
-
Pathways
- WNT Signaling, TCR Signaling, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Thyroid Hormone Synthesis, cAMP Metabolic Process, Myometrial Relaxation and Contraction, Cell-Cell Junction Organization, Regulation of G-Protein Coupled Receptor Protein Signaling, G-protein mediated Events, Signaling Events mediated by VEGFR1 and VEGFR2, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling
Target
-